Oak Thistle LLC Purchases Shares of 90,615 Kenvue Inc. $KVUE

Key Points

• Oak Thistle LLC acquired a new stake of 90,615 shares in Kenvue (NYSE:KVUE) in Q4, valued at about $1.56 million according to the latest 13F filing.
• Kenvue beat estimates in its latest quarter with EPS $0.27 vs. $0.22 expected and revenue of $3.78 billion vs. $3.68 billion, a 3.2% year‑over‑year increase.
• Kenvue pays a quarterly dividend of $0.2075 (annualized $0.83) for a 4.8% yield but has a high payout ratio of 107.79%, and analysts' consensus rating is "Hold" with a $19.50 target.

Oak Thistle LLC acquired a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 90,615 shares of the company's stock, valued at approximately $1,563,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in KVUE. Salomon & Ludwin LLC bought a new stake in Kenvue in the third quarter valued at about $25,000. NBT Bank N A NY raised its position in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company's stock worth $25,000 after purchasing an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company's stock worth $25,000 after purchasing an additional 1,361 shares during the period. Golden State Wealth Management LLC lifted its stake in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company's stock worth $32,000 after purchasing an additional 1,190 shares during the period. Finally, Trust Co. of Vermont boosted its holdings in Kenvue by 50.9% during the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company's stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Kenvue Stock Performance

NYSE KVUE opened at $17.33 on Thursday. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The company has a 50 day moving average of $17.96 and a 200-day moving average of $17.06. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm has a market cap of $33.22 billion, a price-to-earnings ratio of 22.51, a PEG ratio of 3.89 and a beta of 0.61.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period in the prior year, the company earned $0.26 EPS. Kenvue's revenue for the quarter was up 3.2% on a year-over-year basis. On average, equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue's dividend payout ratio is presently 107.79%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on KVUE. Barclays upped their price objective on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Friday, March 6th. UBS Group decreased their price target on Kenvue from $19.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday. Citigroup upped their price target on Kenvue from $18.00 to $20.00 and gave the company a "neutral" rating in a research report on Wednesday, February 18th. Canaccord Genuity Group increased their price objective on Kenvue from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Wednesday, February 18th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Kenvue in a research note on Friday, January 9th. Three analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $19.50.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.